We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
ALAB Rides on Strong Demand for PCIe Solution: A Sign for More Upside?
Read MoreHide Full Article
Key Takeaways
ALAB posted Q4 2025 revenues of $270.6M, up 17% sequentially and 92% year over year.
Astera Labs' Aries PCIe 6 retimers saw 70% 2025 growth, driven by AI accelerator deployments.
ALAB expects Q1 2026 revenues of $286M-$297M, supported by rising PCIe 6 adoption.
Astera Labs (ALAB - Free Report) is benefiting from strong demand for its PCIe solutions, which have also been a major growth driver. In the fourth quarter of 2025, the company reported revenues of $270.6 million, marking a 17% sequential increase and 92% year-over-year growth.
Astera Labs’ product portfolio, including Scorpio, Aries and Taurus, has been a key catalyst. A standout performer in ALAB’s portfolio is its Aries PCIe 6 DSP retimer solutions, which are currently the only PCIe 6 DSP retimer products shipping in high volume. The Aries portfolio saw 70% year-over-year growth in 2025, driven by the increasing deployment of custom AI accelerators at major hyperscalers. With the PCIe 6 transition cycle still in its early stages, ALAB expects further growth as more customers launch PCIe 6 capable AI accelerators and systems in 2026 and beyond.
The Scorpio P-Series family has also been a key growth driver, contributing more than 15% of revenues in 2025. As the only PCIe 6 fabric available in large quantities, Scorpio P-Series is poised to grow in 2026, with shipments to more hyperscalers for next-generation AI platforms. The Scorpio X-Series is likely to move to high-volume production in the second half of 2026, which will further boost revenues.
ALAB's strong demand for PCIe solutions, coupled with its leadership in the AI connectivity space, positions the company for significant upside. Astera Labs expects first-quarter 2026 revenues between $286 million and $297 million, up approximately 6% to 10% year over year.
ALAB Faces Stiff Competition
ALAB is facing stiff competition from other industry players like Marvell Technology (MRVL - Free Report) and Broadcom (AVGO - Free Report) . Both Marvell Technology and Broadcom are making strong efforts in the PCIe retimers market.
Marvell Technology’s expanding portfolio has been noteworthy. The company recently introduced the Structera S 60260, the first 260-lane PCIe 6.0 switch in the industry. It allows for higher-density, lower-latency AI data center scaling by replacing several smaller switches with a single high-radix solution.
Broadcom is expanding its footprint in the PCIe retimers market by developing advanced solutions that enhance signal quality and extend the reach of PCIe connections in high-speed data environments. Broadcom’s launch of PCIe Gen 6 portfolio, featuring high-port switches and retimers tested for interoperability with partners like Micron and Teledyne LeCroy, is a noteworthy development.
ALAB’s Share Price Performance, Valuation and Estimates
ALAB shares have plunged 42.9% in the past six-month period, underperforming the broader Zacks Computer & Technology sector’s decline of 2.4%. The Zacks Internet - Software industry has declined 26.3% in the same time frame.
ALAB Stock Performance
Image Source: Zacks Investment Research
ALAB stock is trading at a premium, with a forward 12-month Price/Sales of 13.44X compared with the Internet - Software industry’s 3.72X. ALAB has a Value Score of F.
ALAB Valuation
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for 2026 earnings is pegged at $2.39 per share, unchanged over the past 30 days. This suggests 29.89% year-over-year growth.
View the Zacks #1 Rank List
Image: Bigstock
ALAB Rides on Strong Demand for PCIe Solution: A Sign for More Upside?
Key Takeaways
Astera Labs (ALAB - Free Report) is benefiting from strong demand for its PCIe solutions, which have also been a major growth driver. In the fourth quarter of 2025, the company reported revenues of $270.6 million, marking a 17% sequential increase and 92% year-over-year growth.
Astera Labs’ product portfolio, including Scorpio, Aries and Taurus, has been a key catalyst. A standout performer in ALAB’s portfolio is its Aries PCIe 6 DSP retimer solutions, which are currently the only PCIe 6 DSP retimer products shipping in high volume. The Aries portfolio saw 70% year-over-year growth in 2025, driven by the increasing deployment of custom AI accelerators at major hyperscalers. With the PCIe 6 transition cycle still in its early stages, ALAB expects further growth as more customers launch PCIe 6 capable AI accelerators and systems in 2026 and beyond.
The Scorpio P-Series family has also been a key growth driver, contributing more than 15% of revenues in 2025. As the only PCIe 6 fabric available in large quantities, Scorpio P-Series is poised to grow in 2026, with shipments to more hyperscalers for next-generation AI platforms. The Scorpio X-Series is likely to move to high-volume production in the second half of 2026, which will further boost revenues.
ALAB's strong demand for PCIe solutions, coupled with its leadership in the AI connectivity space, positions the company for significant upside. Astera Labs expects first-quarter 2026 revenues between $286 million and $297 million, up approximately 6% to 10% year over year.
ALAB Faces Stiff Competition
ALAB is facing stiff competition from other industry players like Marvell Technology (MRVL - Free Report) and Broadcom (AVGO - Free Report) . Both Marvell Technology and Broadcom are making strong efforts in the PCIe retimers market.
Marvell Technology’s expanding portfolio has been noteworthy. The company recently introduced the Structera S 60260, the first 260-lane PCIe 6.0 switch in the industry. It allows for higher-density, lower-latency AI data center scaling by replacing several smaller switches with a single high-radix solution.
Broadcom is expanding its footprint in the PCIe retimers market by developing advanced solutions that enhance signal quality and extend the reach of PCIe connections in high-speed data environments. Broadcom’s launch of PCIe Gen 6 portfolio, featuring high-port switches and retimers tested for interoperability with partners like Micron and Teledyne LeCroy, is a noteworthy development.
ALAB’s Share Price Performance, Valuation and Estimates
ALAB shares have plunged 42.9% in the past six-month period, underperforming the broader Zacks Computer & Technology sector’s decline of 2.4%. The Zacks Internet - Software industry has declined 26.3% in the same time frame.
ALAB Stock Performance
Image Source: Zacks Investment Research
ALAB stock is trading at a premium, with a forward 12-month Price/Sales of 13.44X compared with the Internet - Software industry’s 3.72X. ALAB has a Value Score of F.
ALAB Valuation
Image Source: Zacks Investment Research
The Zacks Consensus Estimate for 2026 earnings is pegged at $2.39 per share, unchanged over the past 30 days. This suggests 29.89% year-over-year growth.
Astera Labs, Inc. Price and Consensus
Astera Labs, Inc. price-consensus-chart | Astera Labs, Inc. Quote
Astera Labs currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.